Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary

Thumbnail
View
Author
de Langen, Adrianus ORCID
Dingemans, Anne-Marie ORCID
Pless, Miklos ORCID
Johnson, Melissa ORCID
MAZIERES, JULIEN ORCID
Mountzios, Giannis ORCID
FELIP, ENRIQUETA ORCID
Date
2025
Permanent link
http://hdl.handle.net/11351/13017
DOI
10.1080/14796694.2025.2474789
ISSN
1744-8301
WOS
001451877500001
PMID
40129223
Share on TwitterShare on FacebookShare on TelegramShare on WhatsappShare on Linkedin

Show full item record
Keywords
Mutation; Non-small-cell lung cancer
Bibliographic citation
de Langen AJ, Melissa LJ, Julien M, Dingemans AMC, Giannis M, Miklos P, et al. Sotorasib versus docetaxel for previously treated KRAS G12C–mutated non–small–cell lung cancer: a plain language summary. Futur Oncol. 2025;21(9):1033-44.
Audience
Professionals
This item appears in following collections

The following license files are associated with this item: